Fluoxetine in endogenous depression and melancholia versus clomipramine
Ginestet, D.
International Clinical Psychopharmacology 4(Suppl 1): 37-40
1989
ISSN/ISBN: 0268-1315 PMID: 2644338 Document Number: 334505
Document emailed within 1 workday
Related Documents
Paholpak, S. 2002: Clomipramine-resistant, fluoxetine-responsive obsessive compulsive disorder: a case report Journal of the Medical Association of Thailand 85(10): 1135-1138Dubois, J.P.; Küng, W.; Theobald, W.; Wirz, B. 1976: Measurement of clomipramine, N-desmethyl-clomipramine, imipramine, and dehydroimipramine in biological fluids by selective ion monitoring, and pharmacokinetics of clomipramine Clinical Chemistry 22(6): 892-897
Hartmann, S. 1999: Melancholia and neurotic depression Psychotherapie Psychosomatik Medizinische Psychologie 49(11): 395-407
Bourgeois, M.; Delalleau, B.; Féline, A.; Ginestet, D.; Lôo, H.; van Amerongen, P. 1991: Tianeptine in episodes of major depression with melancholia and signs of endogenicity Presse Medicale 20(37): 1837-1843
2004: Olanzapine/Fluoxetine (Symbyax) for bipolar depression Medical Letter on Drugs and Therapeutics 46(1178): 23-24
Montgomery, S.A.; Dufour, H.; Brion, S.; Gailledreau, J.; Laqueille, X.; Ferrey, G.; Moron, P.; Parant-Lucena, N.; Singer, L.; Danion, J.M. 1988: The prophylactic efficacy of fluoxetine in unipolar depression British Journal of Psychiatry. Suppl 3: 69-76
Ohmae, S. 2009: The debate concerning the classification of depression that predominantly occurred in the United Kingdom from 1926 to 1957: the discovery and reappraisal of "mild endogenous depression" Seishin Shinkeigaku Zasshi 111(5): 486-501
Champiat, J.C.; Aymard, N.; des Lauriers, A. 1983: Plasma levels of desmethylclomipramine and clomipramine at steady-state in the morning. Correlative analysis and prediction of theoretical blood clomipramine L'Encephale 9(1): 23-36
Straton, J.B.; Cronholm, P. 2002: Are paroxetine, fluoxetine, and sertraline equally effective for depression? Journal of Family Practice 51(3): 285
Sheikha, S.H.; Wagner, K.D.; Wagner, R.F. 1993: Fluoxetine treatment of trichotillomania and depression in a prepubertal child Cutis 51(1): 50-52
Levine, S.; Anderson, D.; Bystritsky, A.; Baron, D. 1990: A report of eight HIV-seropositive patients with major depression responding to fluoxetine Journal of Acquired Immune Deficiency Syndromes 3(11): 1074-1077
McGrath, P.J.; Stewart, J.W.; Petkova, E.; Quitkin, F.M.; Amsterdam, J.D.; Fawcett, J.; Reimherr, F.W.; Rosenbaum, J.F.; Beasley, C.M. 2000: Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression Journal of Clinical Psychiatry 61(7): 518-524
Dalery, J.; Bouhassira, M.; Kress, J.P.; Lancrenon, S.; Tafani, A.; Hantouche, E.G. 1995: Major agitated-anxious versus blunted-retarded depression: differential effects of fluoxetine L'Encephale 21(3): 217-225
Bennie, E.H.; Mullin, J.M.; Martindale, J.J. 1995: A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression Journal of Clinical Psychiatry 56(6): 229-237
Goodnick, P.J.; Fieve, R.R.; Peselow, E.D.; Barouche, F.; Schlegel, A. 1987: Double-blind treatment of major depression with fluoxetine: use of pattern analysis and relation of HAM-D score to CGi change Psychopharmacology Bulletin 23(1): 162-163
Spasojevic, N.; Jovanovic, P.; Dronjak, S. 2012: Chronic fluoxetine treatment affects gene expression of catecholamine enzymes in the heart of depression model rats Indian Journal of Experimental Biology 50(11): 771-775
Beasley, C.M.; Nilsson, M.E.; Koke, S.C.; Gonzales, J.S. 2000: Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: a meta-analysis of the 20-mg/day dose Journal of Clinical Psychiatry 61(10): 722-728
Dominguez, R.A.; Kumar, A.M.; Cua, W. 1996: Lack of change in fluoxetine and norfluoxetine kinetics when switching from fluoxetine to paroxetine Journal of Clinical Psychopharmacology 16(4): 320-323
Breuel, H.P.; Müller-Oerlinghausen, B.; Nickelsen, T.; Heine, P.R. 1995: Pharmacokinetic interactions between lithium and fluoxetine after single and repeated fluoxetine administration in young healthy volunteers International Journal of Clinical Pharmacology and Therapeutics 33(7): 415-419
Maneeton, N.; Thongkam, A.; Maneeton, B. 2010: Cognitive-behavioral therapy added to fluoxetine in major depressive disorder after 4 weeks of fluoxetine-treatment: 16-week open label study Journal of the Medical Association of Thailand 93(3): 337-342